BCEL
Atreca Inc
Price:  
0.15 
USD
Volume:  
655,684.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atreca Intrinsic Value

-13,797.93 %
Upside

What is the intrinsic value of Atreca?

As of 2025-07-05, the Intrinsic Value of Atreca Inc (BCEL) is -20.55 USD. This Atreca valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.15 USD, the upside of Atreca Inc is -13,797.93%.

Is Atreca undervalued or overvalued?

Based on its market price of 0.15 USD and our intrinsic valuation, Atreca Inc (BCEL) is overvalued by 13,797.93%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

0.15 USD
Stock Price
-20.55 USD
Intrinsic Value
Intrinsic Value Details

Atreca Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -20.55 - -20.55 -20.55 -13,797.93%
P/E (33.78) - (76.68) (55.07) -36810.5%
DDM - Stable (31.75) - (935.81) (483.78) -322618.7%
DDM - Multi (17.30) - (425.20) (34.24) -22929.8%

Atreca Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3.57
Beta 4.37
Outstanding shares (mil) 23.79
Enterprise Value (mil) -9.93
Market risk premium 4.60%
Cost of Equity 8.60%
Cost of Debt 5.00%
WACC 6.14%